Wealthspire Advisors (Maryland)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-501
| Closed | -$17K | – | 1465 |
|
|
2019
Q1 | $17K | Buy |
501
+300
| +149% | +$10.2K | ﹤0.01% | 1344 |
|
|
2018
Q4 | $6K | Buy |
201
+13
| +7% | +$388 | ﹤0.01% | 1668 |
|
|
2018
Q3 | $9K | Hold |
188
| – | – | ﹤0.01% | 1564 |
|
|
2018
Q2 | $7K | Hold |
188
| – | – | ﹤0.01% | 1668 |
|
|
2018
Q1 | $6K | Hold |
188
| – | – | ﹤0.01% | 1748 |
|
|
2017
Q4 | $6K | Buy |
188
+175
| +1,346% | +$5.59K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 2395 |
|
|
2016
Q4 | – | Sell |
-345
| Closed | -$7K | – | 1814 |
|
|
2016
Q3 | $7K | Hold |
345
| – | – | ﹤0.01% | 1329 |
|
|
2016
Q2 | $11K | Hold |
345
| – | – | ﹤0.01% | 1187 |
|
|
2016
Q1 | $13K | Hold |
345
| – | – | ﹤0.01% | 1123 |
|
|
2015
Q4 | $15K | Buy |
+345
| New | +$15K | ﹤0.01% | 1071 |
|